Introduction
: 28 year‐old woman with newly diagnosed acute promyelocytic leukemia (APL) undergoing chemotherapy with tretinoin and arsenic trioxide developed new onset headache and binocular diplopia. Neurologic exam was significant for bilateral papilledema and bilateral abducens nerve palsies. MR venogram showed incomplete opacification of the right and left transverse sinuses consistent with thrombosis. Therapeutic dose enoxaparin was started and she was taken to the neuroangiography suite.
Methods
: The left internal jugular vein was catheterized, and the microcatheter was advanced to the opacified left sigmoid sinus. A stent retriever was then deployed and suction thrombectomy was performed, with improvement of the filling defect. Next, the right internal jugular vein was catheterized and the right sigmoid sinus was accessed. Suction thrombectomy was performed, but due to residual thrombus, a stent retriever was deployed in the right transverse sinus and suction thrombectomy was reattempted, with improved recanalization.
Results
: Patient returned to the unit and continued therapeutic enoxaparin. Three days post‐procedure, she developed worsening headache and syncope. She was again taken to neuroangiography suite and the RIJ vein was again catheterized. Venogram after advancing the catheter to the right sigmoid sinus showed multiple filling defects in the proximal right transverse sinus. The catheter was advanced to the sigmoid sinus and a stent retriever was introduced; multiple attempts were made to remove the thrombus. Follow‐up venogram showed significant improvement in recanalization. The LIJ vein was then catheterized and venogram was performed, showing worsening filling defect in the left sigmoid sinus. A stent retriever was deployed in the left transverse sinus and suction thrombectomy was performed, however there was still significant residual thrombus. Suction thrombectomy, another stent retriever attempt and finally balloon angioplasty were then performed with some improvement of patency.. Follow‐up CTV 5 days post‐procedure showed stable venous sinus filling defects. Patient reported gradual improvement of headaches and was transitioned to apixaban. On follow‐up evaluation 3 months post‐procedure, patient reported resolution of headaches and diplopia.
Conclusions
: CVST is generally treated with systemic anticoagulation based on data from two randomized trials, however, ISCVT showed that 13% still decline on anticoagulation. Data regarding the safety and efficacy of MT for CVST is lacking, as well as data regarding patient selection. Our initial decision to treat with MT was due to involvement of posterior fossa and signs of increased intracranial pressure, which are potential prognostic factors for clinical decline with anticoagulation alone from ISCVT. Our patient was initially treated with therapeutic enoxaparin, however developed neurologic deterioration, so she was taken back to the neuroangiography suite. This case report illustrates an example of successful utilization of endovascular therapy for CVST in a patient with acute neurologic deterioration, with good neurologic outcome following recanalization